Flu vaccines that take a page from the COVID-19 vaccine platform are making progress in clinical trials. In a phase 3 trial, Pfizer’s mRNA flu vaccine outperformed a traditional vaccine, researchers ...
The researchers found that mRNA-based COVID-19 vaccines could potentially help patients whose tumors don’t respond well to traditional immunotherapy. When you purchase through links on our site, we ...
The abrupt termination last month of nearly half a billion dollars in US government contracts for mRNA vaccine research rattled scientists working inside and outside industry. The cuts raised alarm ...
Hosted on MSN
Enteromix | Russia's mRNA Cancer vaccine ready to use, shows tumour shrinking results: Report
Russian scientists have developed an mRNA cancer vaccine, named Enteromix, which is now ready for clinical trials. The announcement came from the Federal Medical and Biological Agency (FMBD).
Deborah Fuller receives funding from the National Institutes of Health. She is co-founder and a scientific advisor for two biotech companies developing nucleic acid vaccine technologies that are not ...
The United States may be losing its edge in mRNA technology. The technology, which powered life-saving COVID-19 vaccines and is now rocketing new cancer therapeutics forward, will soon undergo a ...
Academic researchers are worried that the government’s plans to stop investing in the development of messenger RNA vaccines, a technology university scientists first used to help develop the COVID-19 ...
When Tiba Biotech was included in the cancellation of $500 million worth of grants funding mRNA vaccine development, the company was shocked. That’s because Tiba’s project doesn’t use mRNA and is not ...
Founder of the Medulloblastoma Initiative, Fernando Goldsztein, discusses the new MBI-funded research on experimental mRNA vaccines to treat cancer. Watch: Trump puts Washington, DC, police under ...
The Trump administration is terminating 22 contracts focused on developing mRNA vaccines and winding down additional federal investments in mRNA technology, Health and Human Services Secretary Robert ...
(TNND) — Health Secretary Robert F. Kennedy Jr.'s decision to terminate nearly $500 million in government funding for mRNA vaccine development has alarmed public health experts. “This is a deeply ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results